![Joachim Bertram](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joachim Bertram
Chief Tech/Sci/R&D Officer at IBA GmbH
Network origin in Joachim Bertram first degree
Entity | Entity type | Industry | |
---|---|---|---|
IBA GmbH
![]() IBA GmbH Medical/Nursing ServicesHealth Services IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany.
6
| Private Company | Medical/Nursing Services | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joachim Bertram via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
U3 Pharma AG
![]() U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | President | |
Eberhard Karls Universität Tübingen | College/University | Undergraduate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Undergraduate Degree | |
Juno Therapeutics GmbH
![]() Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Biotechnology | Chief Executive Officer | |
Repairon GmbH
![]() Repairon GmbH Repairon GmbH engages in the development, manufacture, and commercialization of induced pluripotent stem cell based tissues for organ repair. It offers therapeutic products such as tissue patches and pouches for the treatment of patients with heart failure caused by ischemic and dilatative cardiomyopathies. The company was founded by Wolfram Zimmermann in 2004 and is headquartered in Goettingen, Germany. | Chief Executive Officer |
Statistics
International
Germany | 9 |
United States | 4 |
Switzerland | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 5 |
Commercial Services | 4 |
Operational
Corporate Officer/Principal | 6 |
Chief Executive Officer | 5 |
Sales & Marketing | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 2 |
Most connected contacts
Insiders | |
---|---|
Mike Rothe | 8 |
Lothar Germeroth | 6 |
Bettina Renker | 1 |
Gisela Mäck | 1 |
Isabel Schuchardt | 1 |
Anna Färger | 1 |
- Stock Market
- Insiders
- Joachim Bertram
- Company connections